{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:30:41Z","timestamp":1790566241315,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012866","name":"Cumming School of Medicine, University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001540","name":"CHEST Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016879","name":"Union Chimique Belge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001232","name":"Royal Australasian College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006630","name":"Lung Foundation Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012128","name":"Austin Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.chest.2021.04.037","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T05:30:49Z","timestamp":1619242249000},"page":"994-1005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease"],"prefix":"10.1016","volume":"160","author":[{"given":"Yet H.","family":"Khor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebal","family":"Abu Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri A.","family":"Johannson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian N.","family":"Glaspole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina A.","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Funke-Chambour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Geiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole S.L.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Ryerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.chest.2021.04.037_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4187\/respcare.06334","article-title":"Exertional desaturation and prescription of ambulatory oxygen therapy in interstitial lung disease","volume":"64","author":"Khor","year":"2019","journal-title":"Respir Care"},{"issue":"4","key":"10.1016\/j.chest.2021.04.037_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.rmed.2006.06.030","article-title":"Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD","volume":"101","author":"Nishiyama","year":"2007","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2021.04.037_bib3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1378\/chest.13-0806","article-title":"Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia","volume":"144","author":"Wallaert","year":"2013","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.chest.2021.04.037_bib4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.200302-219OC","article-title":"Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia","volume":"168","author":"Lama","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2021.04.037_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/rccm.200604-488OC","article-title":"Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test","volume":"174","author":"Flaherty","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.04.037_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/resp.13226","article-title":"Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD","volume":"23","author":"Du Plessis","year":"2018","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.chest.2021.04.037_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1183\/09031936.00190710","article-title":"Ambulatory oxygen in interstitial lung disease","volume":"38","author":"Visca","year":"2011","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.chest.2021.04.037_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","article-title":"Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial","volume":"6","author":"Visca","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2021.04.037_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chest.2020.01.049","article-title":"Ambulatory oxygen in fibrotic interstitial lung disease: a pilot, randomised, triple-blinded, sham-controlled trial","volume":"158","author":"Khor","year":"2020","journal-title":"Chest"},{"issue":"143","key":"10.1016\/j.chest.2021.04.037_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0080-2016","article-title":"Oxygen therapy for interstitial lung disease: a systematic review","volume":"26","author":"Bell","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.chest.2021.04.037_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: the ILD-GAP model","volume":"145","author":"Ryerson","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2021.04.037_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2021.04.037_bib13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2021.04.037_bib14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2021.04.037_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2021.04.037_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1183\/09031936.00150314","article-title":"An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease","volume":"44","author":"Holland","year":"2014","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.04.037_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/resp.12678","article-title":"Clinical practice guideline on adult domiciliary oxygen therapy: executive summary from the Thoracic Society of Australia and New Zealand","volume":"21","author":"McDonald","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.chest.2021.04.037_bib18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"10","key":"10.1016\/j.chest.2021.04.037_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A\u00a0multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2021.04.037_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1479972315571925","article-title":"Be honest and help me prepare for the future: what people with interstitial lung disease want from eduction in pulmonary rehabilitation","volume":"12","author":"Holland","year":"2015","journal-title":"Chron Respir Dis"},{"issue":"1","key":"10.1016\/j.chest.2021.04.037_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2017-000207","article-title":"Understanding the informational needs of patients with IPF and their caregivers: \u2018you get diagnosed, and you ask this question right away, what does this mean?","volume":"7","author":"Ramadurai","year":"2018","journal-title":"BMJ Open Quality"},{"issue":"6","key":"10.1016\/j.chest.2021.04.037_bib22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1513\/AnnalsATS.201611-934OC","article-title":"Oxygen therapy for interstitial lung disease: a mismatch between patient expectations and experiences","volume":"14","author":"Khor","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chest.2021.04.037_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm\/143.2.219","article-title":"Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis","volume":"143","author":"Agust\u00ed","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.chest.2021.04.037_bib24","first-page":"39","article-title":"Ventilation-perfusion relationships in interstitial lung disease","volume":"68","author":"Jernudd-Wilhelmsson","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.chest.2021.04.037_bib25","series-title":"Muscular Exercise and the Lung","first-page":"345","article-title":"Ventilation-perfusion inequality and gas exchange during exercise in lung disease","author":"Wagner","year":"1977"},{"key":"10.1016\/j.chest.2021.04.037_bib26","series-title":"Pulmonary Pathophysiology: The Essentials","first-page":"74","article-title":"Restrictive diseases","author":"West","year":"2012"},{"issue":"2","key":"10.1016\/j.chest.2021.04.037_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01681-2019","article-title":"Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease","volume":"44","author":"Alfieri","year":"2020","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2021.04.037_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1183\/09031936.93.01060510","article-title":"Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis","volume":"1","author":"Agust\u00ed","year":"1988","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2021.04.037_bib29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/thx.43.9.708","article-title":"Functional similarities of asbestosis and cryptogenic fibrosing alveolitis","volume":"43","author":"Markos","year":"1988","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2021.04.037_bib30","first-page":"657180","article-title":"Do we need exercise tests to detect gas exchange impairment in fibrotic idiopathic interstitial pneumonias?","volume":"2012","author":"Wallaert","year":"2012","journal-title":"Pulmon Med"},{"issue":"11","key":"10.1016\/j.chest.2021.04.037_bib31","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1080\/03007995.2019.1647040","article-title":"Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management","volume":"35","author":"Wijsenbeek","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"18","key":"10.1016\/j.chest.2021.04.037_bib32","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2021.04.037_bib33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1378\/chest.122.3.779","article-title":"Predicting survival of lung transplantation candidates with idiopathic interstitial pneumonia: does Pao2 predict survival?","volume":"122","author":"Timmer","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2021.04.037_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1445-5994.1991.tb00445.x","article-title":"Home oxygen therapy: an audit of survival","volume":"21","author":"Crockett","year":"1991","journal-title":"Aust N Z J Med"},{"issue":"11","key":"10.1016\/j.chest.2021.04.037_bib35","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4187\/respcare.06615","article-title":"Predictors of impaired survival in subjects with long-term oxygen therapy","volume":"64","author":"Rantala","year":"2019","journal-title":"Respir Care"},{"key":"10.1016\/j.chest.2021.04.037_bib36","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/thx.2008.101691","article-title":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.chest.2021.04.037_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00421-2019","article-title":"the 02 Delphi Collaborators. Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey","volume":"54","author":"Lim","year":"2019","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.chest.2021.04.037_bib38","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1164\/rccm.201802-0382CI","article-title":"Home oxygen in chronic obstructive pulmonary disease","volume":"197","author":"Lacasse","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2021.04.037_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-155-3-201108020-00008","article-title":"Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society","volume":"155","author":"Qaseem","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.chest.2021.04.037_bib40","doi-asserted-by":"crossref","unstructured":"Jacobs SS, Krishnan JA, Lederer DJ, et\u00a0al. Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;202(10):e121-e141.","DOI":"10.1164\/rccm.202009-3608ST"},{"issue":"3","key":"10.1016\/j.chest.2021.04.037_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.04.037_bib42","doi-asserted-by":"crossref","unstructured":"Khor YH, Ng Y, Barnes H, Goh NSK, McDonald CF, Holland AE. Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review. Eur Respir Rev. 2020;29(157):190158.","DOI":"10.1183\/16000617.0158-2019"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221007625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221007625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:59:59Z","timestamp":1762124399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221007625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0012369221007625"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.04.037","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}